Brown, Lisle/Cummings’s Zimmer Biomet ZBH Stock Holding History

Brown, Lisle/Cummings’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$159K	Buy	1,759 +59	+3%	+$5.41K	0.04%	240
2025 Q4	$153K	Hold	1,700	–	–	0.04%	237
2025 Q3	$167K	Hold	1,700	–	–	0.04%	225
2025 Q2	$155K	Hold	1,700	–	–	0.04%	236
2025 Q1	$192K	Hold	1,700	–	–	0.06%	204
2024 Q4	$180K	Sell	1,700 -300	-15%	-$32.2K	0.05%	211
2024 Q3	$216K	Sell	2,000 -288	-13%	-$31.4K	0.07%	198
2024 Q2	$248K	Sell	2,288 -162	-7%	-$19.1K	0.08%	184
2024 Q1	$323K	Hold	2,450	–	–	0.11%	163
2023 Q4	$298K	Sell	2,450 -175	-7%	-$19.5K	0.11%	166
2023 Q3	$295K	Hold	2,625	–	–	0.13%	147
2023 Q2	$382K	Buy	2,625 +1,700	+184%	+$231K	0.17%	129
2023 Q1	$120K	Hold	925	–	–	0.06%	207
2022 Q4	$118K	Sell	925 -250	-21%	-$29K	0.06%	199
2022 Q3	$123K	Hold	1,175	–	–	0.07%	192
2022 Q2	$123K	Hold	1,175	–	–	0.07%	193
2022 Q1	$150K	Buy	1,175 +16	+1%	+$1.93K	0.07%	189
2021 Q4	$143K	Buy	+1,159	New	+$152K	0.07%	188

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown, Lisle/Cummings's ZBH Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Zimmer Biomet (ZBH) stake by 3.5% in Q1 2026, buying an estimated $5.41K and bringing the position to 1,759 shares worth $159K. The position accounts for 0.04% of the portfolio, ranked #240.

Brown, Lisle/Cummings first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $382K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Brown, Lisle/Cummings held 1,759 shares of Zimmer Biomet worth $159K as of Q1 2026.
Brown, Lisle/Cummings bought 59 Zimmer Biomet shares in Q1 2026, an estimated $5.41K.
Zimmer Biomet made up 0.04% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #240 holding.
Brown, Lisle/Cummings first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
Brown, Lisle/Cummings's Zimmer Biomet position peaked at $382K in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.